Structure-activity relationships for triphenylethylene antiestrogens on hepatic phase-I and phase-II enzyme expression (Q42539588)

2 November 2017

title

Structure-activity relationships for triphenylethylene antiestrogens on hepatic phase-I and phase-II enzyme expression (English)

1 reference

2 November 2017

7

Pitot HC

1 reference

2 November 2017

2

Dragan YP

1 reference

2 November 2017

6

Jordan VC

1 reference

2 November 2017

Nuwaysir EF

1

1 reference

2 November 2017

McCague R

series ordinal

3

1 reference

2 November 2017

Martin P

series ordinal

4

1 reference

2 November 2017

Mann J

series ordinal

5

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 August 1998

1 reference

2 November 2017

published in

Biochemical Pharmacology

1 reference

2 November 2017

volume

56

1 reference

2 November 2017

issue

3

1 reference

2 November 2017

page(s)

321-327

1 reference

The pharmacology and clinical uses of tamoxifen

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Tamoxifen as adjuvant therapy in breast cancer. Current status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Definition of two distinct mechanisms of action of antiestrogens on human breast cancer cell proliferation using hydroxytriphenylethylenes with high affinity for the estrogen receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Comparison between inhibition of protein kinase C and antagonism of calmodulin by tamoxifen analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Variation of the inhibition of calmodulin dependent cyclic AMP phosphodiesterase amongst analogues of tamoxifen; correlations with cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Evidence that tamoxifen binds to calmodulin in a conformation different to that when binding to estrogen receptors, through structure-activity study on ring-fused analogues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Tamoxifen stimulates phospholipase D activity by an estrogen receptor-independent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

The growth inhibition of human breast cancer cells by a novel synthetic progestin involves the induction of transforming growth factor beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Induction of Transforming Growth Factor β by the Antiestrogens Droloxifene, Tamoxifen, and Toremifene in MCF-7 Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Comparative affinity of steroidal and non-steroidal antioestrogens, cholesterol derivatives and compounds with a dialkylamino side chain for the rat liver antioestrogen binding site.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Species specificity of triphenylethylene derivatives and of compounds with a steroidal backbone for human and rat liver antioestrogen binding site (AEBS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Antiestrogen binding sites: general and comparative properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Tamoxifen induces hepatocellular carcinoma in rat liver: a 1-year study with two antiestrogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

The triphenylethylene drug tamoxifen is a strong liver carcinogen in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Risk of endometrial cancer after tamoxifen treatment of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

A mechanistic hypothesis for DNA adduct formation by tamoxifen following hepatic oxidative metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Co-chromatography of a tamoxifen epoxide-deoxyguanylic acid adduct with a major DNA adduct formed in the livers of tamoxifen-treated rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Tamoxifen: evidence by 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Strong intensification of mouse hepatic tamoxifen DNA adduct formation by pretreatment with the sulfotransferase inhibitor and ubiquitous environmental pollutant pentachlorophenol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Definition and antagonism of histamine H 2 -receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Synthesis and estrogen receptor binding of 6,7-dihydro-8-phenyl-9-[4-[2-(dimethylamino)ethoxy] phenyl]-5H-benzocycloheptene, a nonisomerizable analogue of tamoxifen. X-ray crystallographic studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Non-isomerisable antiestrogens related to tamoxifen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Nonisomerizable analogues of (Z)- and (E)-4-hydroxytamoxifen. Synthesis and endocrinological properties of substituted diphenylbenzocycloheptenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Derivatives of tamoxifen. Dependence of antiestrogenicity on the 4-substituent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Antiestrogen basicity--activity relationships: a comparison of the estrogen receptor binding and antiuterotrophic potencies of several analogues of (Z)-1,2-diphenyl-1-[4-[2-(dimethylamino)ethoxy]phenyl]-1-butene (tamoxifen, Nolvadex) having altered

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

In vitro and in vivo binding of toremifene and its metabolites in rat uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Antiestrogenic and antitumor properties of the new triphenylethylene derivative toremifene in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

Effects of the antiestrogen toremifene on growth of the human mammary carcinoma cell line MCF-7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900156-7

10.1016/S0006-2952(98)00156-7

7 January 2021

Identifiers

DOI

1 reference

2 November 2017

1 reference